Company Filing History:
Years Active: 1989
Title: The Innovations of Clark W. Berry
Introduction
Clark W. Berry is a notable inventor based in Danbury, CT (US). He has made significant contributions to the field of chemistry, particularly in the development of radiolabeled compounds. His work has implications for medical diagnostics and research.
Latest Patents
Clark W. Berry holds a patent for a compound known as Radiolabeled benzazepine. This compound is described by the formula: ##STR1## wherein T is tritium. The patent details the intermediates for its preparation and highlights the compound's utility in vivo for detecting the presence of benzodiazepine receptor occupiers in warmblooded animals. He has 1 patent to his name.
Career Highlights
Berry has worked at Hoffmann-La Roche Inc., a leading pharmaceutical company. His role there has allowed him to engage in innovative research and development, contributing to advancements in the field of medicinal chemistry.
Collaborations
Throughout his career, Clark W. Berry has collaborated with esteemed colleagues such as Walter Burger and Arnold A. Liebman. These partnerships have fostered a productive environment for scientific exploration and innovation.
Conclusion
Clark W. Berry's contributions to the field of chemistry, particularly through his patent for Radiolabeled benzazepine, demonstrate his commitment to advancing medical research. His work continues to impact the understanding of benzodiazepine receptors in warmblooded animals.